Entero Historical Cash Flow
| ENTERO Stock | 1,353 6.95 0.52% |
Analysis of Entero Healthcare cash flow over time is an excellent tool to project Entero Healthcare future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 212.8 M or Other Non Cash Items of 404.7 M as it is a great indicator of Entero Healthcare ability to facilitate future growth, repay debt on time or pay out dividends.
Entero |
About Entero Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Entero balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Entero's non-liquid assets can be easily converted into cash.
Entero Healthcare Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Entero Healthcare to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Entero Healthcare operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Entero Healthcare's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Entero Healthcare current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entero Healthcare Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At present, Entero Healthcare's Change In Cash is projected to increase significantly based on the last few years of reporting. The current year's Begin Period Cash Flow is expected to grow to about 341.6 M, whereas Change To Inventory is forecasted to decline to (549.8 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Other Non Cash Items | 448.8M | 467.8M | 537.9M | 404.7M | Depreciation | 242.4M | 250.2M | 287.7M | 212.8M |
Entero Healthcare cash flow statement Correlations
Click cells to compare fundamentals
Entero Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Entero Healthcare cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (489.5M) | (301.0M) | (193.9M) | (581.8M) | (523.6M) | (549.8M) | |
| Change In Cash | (108.4M) | 141.9M | (211.5M) | 1.2B | 1.4B | 1.5B | |
| Free Cash Flow | (782.1M) | (451.3M) | (508.3M) | (420.3M) | (483.3M) | (507.5M) | |
| Change In Working Capital | (959.3M) | (460.7M) | (1.0B) | (1.5B) | (1.3B) | (1.4B) | |
| Begin Period Cash Flow | 431.5M | 323.1M | 465.1M | 253.6M | 228.3M | 341.6M | |
| Other Cashflows From Financing Activities | 534.8M | 641.2M | (159.9M) | (383.0M) | (344.7M) | (327.4M) | |
| Depreciation | 162.8M | 197.5M | 242.4M | 250.2M | 287.7M | 212.8M | |
| Other Non Cash Items | 173.9M | 255.4M | 448.8M | 467.8M | 537.9M | 404.7M | |
| Capital Expenditures | 95.3M | 98.7M | 55.2M | 54.2M | 48.7M | 46.3M | |
| Total Cash From Operating Activities | (686.8M) | (352.7M) | (453.2M) | (366.1M) | (421.0M) | (442.1M) | |
| Change To Account Receivables | (119.2M) | (682.2M) | (1.3B) | (667.2M) | (600.5M) | (630.5M) | |
| Net Income | (108.4M) | (198.1M) | (36.9M) | 355.6M | 408.9M | 429.3M | |
| Total Cash From Financing Activities | 887.1M | 2.1B | 727.6M | 8.6B | 9.9B | 10.4B | |
| End Period Cash Flow | 323.1M | 465.1M | 253.6M | 1.5B | 1.7B | 1.8B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Entero Stock
The Cash Flow Statement is a financial statement that shows how changes in Entero balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Entero's non-liquid assets can be easily converted into cash.